Rapid Micro Biosystems (RPID) Non-Current Debt (2020 - 2026)

Rapid Micro Biosystems' (RPID) quarterly Non-Current Debt came in at $19.1 million in Q1 2026, up 0.8% quarter-over-quarter from $18.9 million in Q4 2025.

Rapid Micro Biosystems (RPID) Non-Current Debt (2020 - 2026) Analysis & Trends

Rapid Micro Biosystems has disclosed Non-Current Debt across 4 years of filings, most recently posting $19.1 million for Q1 2026.

  • Non-Current Debt for Q1 2026 came in at $19.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $19.1 million (changed N/A YoY), and the FY2025 annual result was $18.9 million, changed N/A from the prior year.
  • Non-Current Debt came in at $19.1 million for Q1 2026 at Rapid Micro Biosystems, up from $18.9 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $19.1 million in Q1 2026 to a low of $18.8 million in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 29.64 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 14.22 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 27.88 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 1.81 Bn
10 Rapid Micro Biosystems 77.24 Mn 54.29 Mn 371,000.00 19.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.05 Mn
Mar 31, 2026 19.05 Mn
Dec 31, 2025 18.90 Mn
Dec 31, 2025 18.90 Mn
Sep 30, 2025 18.83 Mn
Sep 30, 2025 18.83 Mn
Jun 30, 2021 24.98 Mn
Jun 30, 2021 24.98 Mn
Dec 31, 2020 24.81 Mn
Dec 31, 2020 24.81 Mn